The Journal of Immunology, Vol 137, Issue 8 2646-2652, Copyright © 1986 by American Association of Immunologists

ARTICLES

Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation

G Chaudhri, IA Clark, NH Hunt, WB Cowden and R Ceredig

Because oxygen-centered free radicals are involved in cell-mediated immune responses, we examined the possibility that these reactive species could also have a role in the lymphoproliferative response to alloantigens in the mixed lymphocyte culture (MLC). Three classes of agents that prevent the formation, or damaging effects, of oxygen radicals were tested: the non-permeant electron acceptor ferricyanide; the iron chelators desferrioxamine, desferrithiocin, octanohydroxamic acid, and pyridoxal isonicotinoyl hydrazone, which are thought to be capable of preventing the iron-catalyzed reduction of H2O2 to more reactive species; and the lipid-soluble free radical scavenger butylated hydroxyanisole. These compounds inhibited the proliferation of all potential responder cells in the MLC in a dose-dependent manner. Inhibition was observed only if these agents were present early (less than 40 hr) in the MLC; if added later, their effects were significantly reduced. In contrast, the interleukin 2 (IL 2)-dependent proliferation of CTLL-2 cells or Con A blasts was not affected by these compounds at concentrations that inhibited proliferation in MLC by greater than 90%. Interleukin 1 (IL 1) production by peritoneal exudate cells and IL 2 and IL 1 levels in MLC were not affected by any of the agents tested. By flow microfluorometry, the expression of IL 2 receptors on stimulated T cells was found to be inhibited in the presence of these drugs. Taken together, the data point to an important role for free radical-mediated processes during the early stages of T lymphocyte activation, before IL 2 receptor expression.

This article has been cited by other articles:

				R. D. Michalek, K. J. Nelson, B. C. Holbrook, J. S. Yi, D. Stridiron, L. W. Daniel, J. S. Fetrow, S. B. King, L. B. Poole, and J. M. Grayson The Requirement of Reversible Cysteine Sulfenic Acid Formation for T Cell Activation and Function J. Immunol., November 15, 2007; 179(10): 6456 - 6467. [Abstract] [Full Text] [PDF]

				Z. Yang, Y.-J. Day, M.-C. Toufektsian, Y. Xu, S. I. Ramos, M. A. Marshall, B. A. French, and J. Linden Myocardial Infarct-Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes Circulation, November 7, 2006; 114(19): 2056 - 2064. [Abstract] [Full Text] [PDF]

				N. G. Laniewski and J. M. Grayson Antioxidant Treatment Reduces Expansion and Contraction of Antigen-Specific CD8+ T Cells during Primary but Not Secondary Viral Infection J. Virol., October 15, 2004; 78(20): 11246 - 11257. [Abstract] [Full Text] [PDF]

				V. Verhasselt, W. Vanden Berghe, N. Vanderheyde, F. Willems, G. Haegeman, and M. Goldman N-Acetyl-L-Cysteine Inhibits Primary Human T Cell Responses at the Dendritic Cell Level: Association with NF-{kappa}B Inhibition J. Immunol., March 1, 1999; 162(5): 2569 - 2574. [Abstract] [Full Text] [PDF]

				S. Tan, Y. Sagara, Y. Liu, P. Maher, and D. Schubert The Regulation of Reactive Oxygen Species Production during Programmed Cell Death J. Cell Biol., June 15, 1998; 141(6): 1423 - 1432. [Abstract] [Full Text] [PDF]